From Evidence to Action in LifeCourse Prevention

At the 5th Life Course Immunization Summit, the Working Group on LifeCourse Immunization and Health Systems Resilience examined how COVID-19 exposed the fragility of single-focused health systems and shifted public attitudes towards vaccination. Across seven themes, from health systems resilience to maternal vaccination, the Group set out observations, challenges, strategies, and a slate of actions to advance a life-course approach to immunization.

This Policy Meeting report examines how online vaccine misinformation can be better countered. Presented at the 11th Excellence in Pediatrics Conference in December 2019, it brings together expert briefings on the need for evidence-based credible information and vaccinology training, how healthcare professionals can engage effectively on social media, and interventions from the WHO, CPME and EPSA, alongside country experience from Latvia and Serbia and a proposed action plan for 2020/2021.

This Policy Meeting report examines educational gaps and behavioral change in vaccination uptake, among both healthcare professionals and parents. Presented at the 11th Excellence in Pediatrics Conference, it brings together expert briefings on improving HCP education and on applying adult learning principles and motivational interviewing to conversations with parents, alongside country updates from Serbia, Spain and Finland and a proposed action plan for 2020/2021.

The report Influenza Vaccinations examined how the arrival of COVID-19 vaccines reshaped the flu season — from delivering both vaccines together and sustaining supply, to persistent low uptake among healthcare workers and the role of women and community HCPs in reaching high-risk groups. The Group set out observations, challenges, strategies and a full slate of 2021/22 campaigns.

With flu coverage historically low after COVID, sustaining influenza vaccination has become a test of health-system resilience. This report examines three themes: protecting and expanding influenza vaccine funding, sharpening the messaging and weighing new vaccine technology against the 75% coverage target, and lifting uptake among the sub-groups that matter most — pregnant women, children, people with chronic conditions and healthcare professionals.

A draft working-group report from the 6th LifeCourse Immunization Summit. Structured as paired observations, challenges, and proposed strategies, it examines what makes vaccination programs succeed across the life course — from digitizing registries and training all healthcare professionals to reaching older adults, pregnant women, and adolescents — and distills the cross-cutting lessons learned from the COVID-19 response.

Why do vaccination systems fail the communities they serve? Insights from the 2025 LifeCourse Prevention Summit on trust, access, and the case for system change

Most infants hospitalized with RSV are otherwise healthy. Why universal prevention outperforms targeted strategies - insights from the 2025 LifeCourse Summit.

When communities are engaged as partners, vaccination programs work better. Insights from the 2025 LifeCourse Summit on co-design, engagement, and equity.

The tools for RSV prevention work; coverage decides the impact. Multi-country evidence on reaching every infant, from the 2025 LifeCourse Prevention Summit.

Free vaccines don't guarantee equal access. Why child poverty drives vaccination inequity, and why reducing it is a prerequisite.

RSV drives pneumococcal disease and shapes lung function into adulthood. Why its lasting burden is the strongest case for early universal prevention.